An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. (Q36897999)
Jump to navigation
Jump to search
scientific article published on July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. |
scientific article published on July 1998 |
Statements
An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells (English)
Wada M
Hosotani R
Lee JU
Koshiba T
Fujimoto K
Miyamoto Y
Tsuji S
Nakajima S
Okuyama A